News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
The collaboration between Penn and PaxeraHealth will concentrate on developing imaging algorithms to detect liver cancer in addition to covid detection via lung ultrasounds.
Covid-19 vaccine royalties from Karikó and Weissman's research are being re-invested into Penn’s research portfolio to support further discovery of life-saving therapies and technologies.
Learn about the key highlights and events from the 12th Annual Philly Tech Week.
Penn Medicine and Children’s Hospital of Philadelphia were in the spotlight at the Tribeca Film Festival in New York City, where the documentary “Of Medicine and Miracles" premiered.
Read about Penn's latest expansion within the innovation ecosystem.
Read about how May graduates won the 2022 President's Sustainability Prize for their device that reduces microplastic pollution.
Vittoria Biotherapeutics' mission is to overcome current limitations of chimeric antigen receptor (CAR) T-cell therapeutics by using its unique cell engineering and gene editing technologies.
From May 6 - 12, PCI participated in the 12th annual Philly Tech Week, a conference hosted by Technical.ly Philly, to showcase some of the city's best technology and innovation.
Abrax Japan entered into an exclusive licensing agreement for certain Penn-owned inventions relating to the therapeutic effects of thymic stromal lymphopoietin (TSLP).
Awarded annually, the President’s Innovation Prize empowers Penn students to design and undertake a post-graduation startup company that makes a positive, lasting difference in the world.